Loading stock…

JBS N.V. (JBS) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

JBSJBS N.V.

Revenue FY25$86.2B

GROWTH RATING↗

AVERAGE42 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+7%6

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-57%1

EPS growth, FY27E+75%10

EPS growth, FY28E+70%10

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

A mid-pack grower, ahead of 42% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, in line with the market.5/10

Revenue grew 7%/yr over the last 3 years and is set to keep growing around 5%/yr.

Earnings are set to grow faster than sales (EPS about 70%/yr vs revenue 5%/yr), so margins should widen. One year dips: EPS falls 57% next year.

WEAKNESSES

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: the five-year outlook is thin.

03Price Momentum

Is the market behind it right now?

JBSJBS N.V.

Total return Current−15.1%

Price return Current−15.1%

MOMENTUM RATING↗

WEAK33 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-5%5

3-month return+4%7

YTD return-8%4

MID & LONG-TERM▾SCORE

% of 52-week high71%4

1-year return+3%5

3-year return-5%3

5-year return-5%3

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+4%).

WATCH

It's up 3% over the past year, but 29% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-5%) and so far this year (-8%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-4.7% over three years and -4.7% over five), behind 70% of the market.

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on JBS N.V.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

JBSJBS N.V.

Revenue FY25$86.2B

GROWTH RATING↗

AVERAGE42 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+7%6

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-57%1

EPS growth, FY27E+75%10

EPS growth, FY28E+70%10

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

A mid-pack grower, ahead of 42% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, in line with the market.5/10

Revenue grew 7%/yr over the last 3 years and is set to keep growing around 5%/yr.

Earnings are set to grow faster than sales (EPS about 70%/yr vs revenue 5%/yr), so margins should widen. One year dips: EPS falls 57% next year.

WEAKNESSES

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: the five-year outlook is thin.

03Price Momentum

Is the market behind it right now?

JBSJBS N.V.

Total return Current−15.1%

Price return Current−15.1%

MOMENTUM RATING↗

WEAK33 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-5%5

3-month return+4%7

YTD return-8%4

MID & LONG-TERM▾SCORE

% of 52-week high71%4

1-year return+3%5

3-year return-5%3

5-year return-5%3

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+4%).

WATCH

It's up 3% over the past year, but 29% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-5%) and so far this year (-8%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-4.7% over three years and -4.7% over five), behind 70% of the market.

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on JBS N.V.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

JBS N.V.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on JBS N.V.. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on JBS N.V.. Get the full investment case.

Premium